Valuation: Viatris Inc.

Market Cap 22.79B 20.76B 19.13B 17.4B 32.64B 2,110B 34.31B 233B 92.53B 1,153B 85.51B 83.71B 3,618B P/E 2026 *
-76.5x
P/E 2027 * 64.1x
Enterprise Value 34.44B 31.36B 28.9B 26.29B 49.32B 3,189B 51.83B 352B 140B 1,742B 129B 126B 5,466B EV / Sales 2026 *
2.31x
EV / Sales 2027 * 2.18x
Free-Float
90.78%
Yield 2026 *
2.51%
Yield 2027 * 2.63%
1 day-1.53%
1 week-5.62%
Current month+3.23%
1 month+5.36%
3 months+21.90%
6 months+18.44%
Current year+57.83%
1 week 19.43
Extreme 19.43
20.99
1 month 17.86
Extreme 17.86
21.2
Current year 12.19
Extreme 12.19
21.2
1 year 10.15
Extreme 10.15
21.2
3 years 6.85
Extreme 6.85
21.2
5 years 6.85
Extreme 6.85
21.2
10 years 6.85
Extreme 6.85
47.82
Manager TitleAgeSince
Chief Executive Officer 63 01/04/2023
Director of Finance/CFO 59 08/05/2026
Chief Tech/Sci/R&D Officer - 15/12/2023
Director TitleAgeSince
Director/Board Member 78 16/11/2020
Director/Board Member 78 16/11/2020
Director/Board Member 62 16/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

2,469 0.0002%
30/09/26 Free

Director

2,117 0.0002%
15/08/26 Exercice

Chief Administrative Officer

63,631 0.0054%
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%-5.62%+92.84%+107.50% 22.79B
-0.02%-6.34%+29.59%+126.24% 1,204B
+1.75%-4.83%+33.92%+81.42% 643B
+1.84%-2.09%+25.90%+108.86% 501B
-0.60%-1.95%+27.26%+67.32% 378B
+1.28%-8.76%+41.96%+31.30% 327B
+0.41%-4.70%+27.23%+51.59% 285B
+0.81%-4.08%-1.74%+32.71% 270B
+0.16%-6.04%+30.19%+64.89% 237B
+0.80%-0.02%+34.45%+121.12% 207B
Average +0.48%-4.34%+34.16%+79.29% 408B
Weighted average by Cap. +0.66%-4.70%+28.99%+88.57%

Financials

2026 *2027 *
Net sales 14.9B 13.57B 12.5B 11.37B 21.34B 1,379B 22.42B 152B 60.48B 753B 55.89B 54.72B 2,365B 15.8B 14.39B 13.26B 12.07B 22.63B 1,463B 23.79B 161B 64.16B 799B 59.3B 58.05B 2,509B
Net income -301M -274M -252M -230M -431M -27.85B -453M -3.07B -1.22B -15.21B -1.13B -1.1B -47.75B 363M 330M 304M 277M 519M 33.59B 546M 3.7B 1.47B 18.34B 1.36B 1.33B 57.57B
Net Debt 11.64B 10.61B 9.77B 8.89B 16.68B 1,078B 17.53B 119B 47.27B 589B 43.69B 42.77B 1,848B 11.62B 10.59B 9.75B 8.87B 16.65B 1,076B 17.49B 119B 47.19B 588B 43.61B 42.69B 1,845B
Projected Income Statement - Annual - Viatris Inc.
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. Its Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. Its JANZ segment consists of operations in Japan, Australia and New Zealand. The Company's Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. The Company produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a wide variety of noncommunicable and infectious diseases. It is also expertise in non-opioid pain management.
Employees
30,000
Date Price Change Volume
20/11/26 $19.62 -1.31% 4,852,735
19/11/26 $19.88 -1.97% 9,167,653
18/11/26 $20.28 -0.83% 13,271,634
17/11/26 $20.45 -1.40% 10,384,303
16/11/26 $20.74 -0.38% 15,678,651
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Viatris Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
19.88USD
Average target price
21.60USD
Spread / Average Target
+8.65%
  1. Stock Market
  2. Stocks
  3. VTRS Stock